Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Comparing two breathing exercises for people with chronic obstructive lung disease

Tests Pilates breathing against pursed lip breathing in adults with COPD.

Plain-language title generated from the registry record
Registry title: Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

Key facts

Where
Rawalpindi, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 64 years old?

Source: NCT07177976, who can take part

Where in Pakistan

  • Foundation University College of Physical Therapy, Islamabad, 44000Rawalpindi, PakistanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Foundation University Islamabad
Trial code
NCT07177976
Record updated
7 October 2025
Original description
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.Read full original descriptionShow less

Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.

Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management

Inclusion: Age between 40-64 years; Both genders (male and female); Grade 1-3 on mMRC scale of dyspnea; COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted.

Exclusion: Patients diagnosed with acute infection; Moderate, severe and very severe stage of COPD according to GOLD classification; Patients having acute exerbation of COPD; Patients unable to follow command and instructions.

ClinicalTrials.gov NCT07177976